Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

cultured Lentinula edodes mycelia extract

An orally bioavailable capsule-based formulation of a standardized extract of cultured Lentinula edodes (Shiitake mushroom) mycelia (ECLM), which is high in the polysaccharides beta- and alpha-glucans, with potential antioxidant, immunomodulating and antineoplastic activities. Upon oral administration, the cultured Lentinula edodes mycelia extract activates the immune system, by binding to toll-like receptors (TLRs), specifically TLR-4, and induces the activation of dendritic cells (DCs), natural killer (NK) cells, macrophages and T cells and the release of cytokines. This may clear human papillomavirus (HPV) infections.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:cultured Lentinula edodes mycelia extract AHCC
L. edodes mycelia extract AHCC
L. edodes mycelia extract AHCC
Lentinula edodes mycelia extract
standardized extract of cultured Lentinula edodes mycelia
Yinuojin Ruanjiaonang
Abbreviation:ECLM
Code name:AHCC
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search